Axonics, Inc. today announced that it has received regulatory approval from the Therapeutic Goods Administration (TGA) for marketing the Axonics F15tm recharge-free sacral neuromodulation (SNM) system in Australia to treat adults with overactive.
Axonics, Inc. (NASDAQ:AXNX) Short Interest Up 17.4% in April themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Axonics, Inc. (NASDAQ:AXNX – Get Free Report) has been given an average recommendation of “Hold” by the thirteen brokerages that are presently covering the stock, MarketBeat reports. Eight investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year target price among analysts […]
Axonics Responds to ITC Action by Medtronic streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.